Soluble thrombomodulin and coronary heart disease
- PMID: 12865735
- DOI: 10.1097/00041433-200308000-00006
Soluble thrombomodulin and coronary heart disease
Abstract
Purpose of review: Endothelial thrombomodulin is a major vasoprotective molecule. The membrane thrombomodulin is digested by proteases and the degradation products are detectable in circulating blood. The purpose of this review is to provide recent information regarding the relationship of soluble thrombomodulin with coronary heart disease.
Recent findings: Results from a population-based, prospective, coronary heart disease, case-cohort study reveal an inverse relationship between plasma soluble thrombomodulin and the relative risk of coronary heart disease. Participants in this study were healthy subjects without acute thrombotic events. They were followed, and coronary heart disease events were ascertained. Individuals with a high level of soluble thrombomodulin are associated with a significant reduction in the relative risk of coronary heart disease events. There is a significant interaction between soluble thrombomodulin and soluble intercellular adhesion molecule-1 in predicting the risk of coronary heart disease events. Individuals with a high soluble thrombomodulin level do not have an increased risk of coronary heart disease, even when soluble intercellular adhesion molecule-1 is at the highest levels. In contrast, at low soluble thrombomodulin levels, soluble intercellular adhesion molecule-1 has a 'dose-dependent' association with coronary heart disease risk. These results suggest an interplay between vasoprotective and pro-inflammatory endothelial molecules. Soluble thrombomodulin and its parent molecule appear to play a predominant role in determinations of the risk of coronary heart disease events.
Summary: The soluble thrombomodulin level in plasma is an independent risk factor for coronary heart disease. It is inversely associated with coronary heart disease risk. Combinatorial analysis of soluble thrombomodulin and soluble intercellular adhesion molecule-1 provides a more specific assessment of coronary heart disease risk in middle-aged subjects.
Similar articles
-
Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study.Lancet. 1999 May 22;353(9166):1729-34. doi: 10.1016/s0140-6736(98)09057-6. Lancet. 1999. PMID: 10347984
-
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease.Circulation. 2003 Apr 8;107(13):1729-32. doi: 10.1161/01.CIR.0000064894.97094.4F. Epub 2003 Mar 31. Circulation. 2003. PMID: 12668515
-
A possible explanation of statistical interaction, with application to the effects of soluble thrombomodulin and soluble intercellular adhesion molecule-1 on coronary heart disease.Circulation. 2003 Dec 23;108(25):E175; author reply E175. doi: 10.1161/01.CIR.0000108175.90859.91. Circulation. 2003. PMID: 14691032 No abstract available.
-
Correlation between soluble markers of endothelial dysfunction in patients with renal failure.Am J Nephrol. 2002 Jan-Feb;22(1):42-7. doi: 10.1159/000046673. Am J Nephrol. 2002. PMID: 11919402
-
Deciphering Endothelial Dysfunction in the HIV-Infected Population.Adv Exp Med Biol. 2019;1134:193-215. doi: 10.1007/978-3-030-12668-1_11. Adv Exp Med Biol. 2019. PMID: 30919339 Review.
Cited by
-
Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis.BMC Nephrol. 2011 Jan 26;12:3. doi: 10.1186/1471-2369-12-3. BMC Nephrol. 2011. PMID: 21269477 Free PMC article.
-
The Multifaceted Roles of Thrombomodulin: Anti-coagulation, Anti-inflammation, and Anti-tumor Potential.Curr Pharm Des. 2025;31(21):1673-1682. doi: 10.2174/0113816128335289241218161938. Curr Pharm Des. 2025. PMID: 39901541 Review.
-
Thrombomodulin and its role in inflammation.Semin Immunopathol. 2012 Jan;34(1):107-25. doi: 10.1007/s00281-011-0282-8. Epub 2011 Jul 31. Semin Immunopathol. 2012. PMID: 21805323 Review.
-
Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.TH Open. 2022 Jul 11;6(3):e194-e212. doi: 10.1055/a-1801-2055. eCollection 2022 Jul. TH Open. 2022. PMID: 36046203 Free PMC article. Review.
-
Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1585-97. doi: 10.1152/ajpheart.00096.2013. Epub 2013 Apr 19. Am J Physiol Heart Circ Physiol. 2013. PMID: 23604713 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials